Tony Fiorino
Director/Board Member at IMMUNE PHARMACEUTICALS, INC.
Profile
Founder of EnzymeRx LLC, Anthony S.
Fiorino is a businessperson who has been the head of 5 different companies is on the board of Immune Pharmaceuticals, Inc. (former CEO, COO, Chief Medical Officer & Director).
He previously held the position of Chief Executive Officer at Brainstorm Cell Therapeutics, Inc., President & Chief Executive Officer at EnzymeRx LLC, President for Alchimia Partners LLC, Chief Medical Officer at electroCore, Inc., Managing Director at Greywall Asset Management LP, Portfolio Manager at Pequot Capital Management, Inc., President & Chief Executive Officer for Triumvira Immunologics, Inc., Principal at Sands Point Partners LP and Principal at JPMorgan Services (Malaysia) Sdn.
Bhd.
Anthony S.
Fiorino received an undergraduate degree from Massachusetts Institute of Technology, a doctorate from Albert Einstein College of Medicine, Inc. and a doctorate from Albert Einstein College of Medicine, Inc.
Tony Fiorino active positions
Companies | Position | Start |
---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Director/Board Member | 2019-03-05 |
Former positions of Tony Fiorino
Companies | Position | End |
---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Director/Board Member | 2017-10-08 |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Chief Executive Officer | 2016-12-31 |
BRAINSTORM CELL THERAPEUTICS INC. | Chief Executive Officer | 2015-10-31 |
Greywall Asset Management LP
Greywall Asset Management LP Investment ManagersFinance Greywall Asset Management LP is a hedge fund manager located in New York City. | Corporate Officer/Principal | 2014-04-30 |
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Chief Executive Officer | 2012-11-30 |
Training of Tony Fiorino
Massachusetts Institute of Technology | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
ELECTROCORE, INC. | Health Technology |
Private companies | 8 |
---|---|
Pequot Capital Management, Inc.
Pequot Capital Management, Inc. Investment ManagersFinance Founded in 1998 by Arthur J. Samberg, Pequot Capital Management Inc. is a hedge fund manager headquartered in Wilton, Connecticut with offices in New York City and Los Angeles. They manage the Pequot Family of Funds. | Finance |
Sands Point Partners LP | |
JPMorgan Services (Malaysia) Sdn. Bhd.
JPMorgan Services (Malaysia) Sdn. Bhd. Financial ConglomeratesFinance Part of JPMorgan Chase & Co., JPMorgan Services (Malaysia) Sdn. Bhd. operates a Malaysian investment company. Steve Clayton has been the CEO of the private company since 2011. | Finance |
EnzymeRx LLC
EnzymeRx LLC BiotechnologyHealth Technology EnzymeRx LLC develops pegylated uricase for the treatment of resistant and refractory related indications. The company was founded by Anthony S Fiorino in 2008 and is headquartered in Paramus, NJ. | Health Technology |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Greywall Asset Management LP
Greywall Asset Management LP Investment ManagersFinance Greywall Asset Management LP is a hedge fund manager located in New York City. | Finance |
Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada. | Health Technology |
Alchimia Partners LLC
Alchimia Partners LLC Miscellaneous Commercial ServicesCommercial Services Alchimia Partners LLC provides business support services. The private company is based in Teaneck. | Commercial Services |